Skip To Main Content
Karen Blum on Muck Rack

Karen Blum

Washington, D.C.
As seen in: Association of Health Care Journalists, Infectious Disease Special Edition, The Hub (Johns Hopkins University), Baltimore Sun, Medscape, Medscape Noticias Médicas, AARP, MedPage Today, Fodor's Travel, MdEdge ObGyn, Internal Medicine News, MDEdge and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Karen

Contact Karen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

GLP-1s May Reduce Overdose Risk, Even After Discontinuation

|
By Karen Blum
| Medscape Verified
People with a history of alcohol, opioid, or substance overdose who were later started on GLP-1 receptor agonist medications had a significantly lower risk for a repeat overdose, even if they discontinued it, according to an Epic Research study.
Open in Who Shared Issue with article?

Genetics and Drugs: A Tricky Interplay

|
By Karen Blum
| Anesthesiology News Verified
Originally published by our sister publication Pharmacy Practice News Pharmacogenomic testing to determine how a patient’s genetic variations influence their response to medications can be helpful in some cases in selecting medications, but it’s still an evolving science, speakers noted during the ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas. “We think about pharmacogenomics as being something that is a black-and-white report, and it very
Open in Who Shared Issue with article?

Managing reimbursement of molecular testing for infectious disease

|
By Karen Blum
| Clinical Laboratory News (ADLM)
Getting proper reimbursement to conduct genetic and molecular testing for infectious disease has become an increasing concern for laboratories. CLN spoke with Ashley Zarling, director of business development and marketing with Doc Lab, for tips and insight. Zarling provides consulting to laboratory professionals in physicians’ offices and reference laboratories to help them communicate effectively with payers and navigate the reimbursement process.
Open in Who Shared Issue with article?
See all 438 licensed articles (452 Total)